Please use this identifier to cite or link to this item:
https://hdl.handle.net/10419/56346
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ekelund, Mats | en |
dc.date.accessioned | 2012-02-29 | - |
dc.date.accessioned | 2012-03-28T13:10:51Z | - |
dc.date.available | 2012-03-28T13:10:51Z | - |
dc.date.issued | 2000 | - |
dc.identifier.uri | http://hdl.handle.net/10419/56346 | - |
dc.language.iso | swe | en |
dc.publisher | |aStockholm School of Economics, The Economic Research Institute (EFI) |cStockholm | en |
dc.relation.ispartofseries | |aSSE/EFI Working Paper Series in Economics and Finance |x404 | en |
dc.subject.jel | H51 | en |
dc.subject.jel | I18 | en |
dc.subject.ddc | 330 | en |
dc.title | Nya förutsättningar för svensk läkemedelsmarknad | - |
dc.type | Working Paper | en |
dc.identifier.ppn | 687679990 | en |
dc.rights | http://www.econstor.eu/dspace/Nutzungsbedingungen | en |
Files in This Item:
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.